Press Releases
Public Relations: Andrew Noble
May 19, 2026
New
DNAnexus Scales AI-Driven Capabilities
17-Year Multiomics Pioneer Powers Next Era of Precision Health
Read More
May 07, 2026
DNAnexus Wins MedTech Breakthrough’s PharmaTech Innovation Award
Enterprise Leading Orchestration Platform Honored for AI-Enabled Infrastructure and Next-Gen Digital Health & Medical Technology
Read More
May 07, 2026
Longitude Prize on ALS Announces Stage 1 Discovery Award Winners
Meet the Discovery Awardees of the Longitude Prize on ALS, awarded £100,000 each, as well as access to the Prize datasets and a technical support package to drive their computational work. These 20 pioneering, global and multidisciplinary teams are using cutting-edge AI to unlock the complexity of ALS.
Read More
November 10, 2025
EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform
EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.
Read More
October 22, 2025
DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award
DNAnexus earned recognition from Frost & Sullivan for its leadership in precision health informatics. The award highlights its groundbreaking platform for integrating complex clinical, multi-omics, and real-world data to deliver secure, actionable insights.
Read More
News
May 26, 2026
New
Programming biology: next-gen AI firms raise billions to design better medicines
Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.
May 19, 2026
DNAnexus AI Products
DNAnexus has launched a number of software products and enhancements that are enabled by artificial intelligence.
Read More
May 01, 2026
How are companies distinguishing between “moonshot” automation and validated digital tools that can be deployed today?
Todd Oakland, Ph.D., Senior Vice President, General Manager, Biopharma RX/DX, DNAnexus, joins a roundtable of experts to discuss the pace of technological innovation and how to tell when a tool is production-ready.
Read More
March 31, 2026
AI-led selloff in contract research firms may be misjudging disruption risk
Shares of contract research organizations have tumbled on fears that advances in artificial intelligence could allow drugmakers to take clinical trial work in-house, but industry experts say the selloff overestimates how far the technology can replace the sector's core capabilities.
Read More
February 02, 2026
Accelerating the drug regulatory process through a federated cloud ecosystem
Cloud-based regulatory platforms are transitioning from pilots to practical solutions. Sustainable adoption now relies on global coordination, continued trust and a shift towards federated, interoperable models.
Read More
"Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases."
James R. Downing
President & CEO
St. Judes Children’s Research Hospital